Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 16, 2017 Filed May 19, 2017 00:48 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 3,179 | $19.55 | $62,149.45 |
DisclosureSEC source: 0001209191-17-033769 · doc4.xml · nonDerivative · entry 1 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,091 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F3 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| May 16, 2017 Filed May 19, 2017 00:47 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 2,959 | $19.55 | $57,848.45 |
DisclosureSEC source: 0001209191-17-033768 · doc4.xml · nonDerivative · entry 1 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,689 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F3 · balance_after: This number includes 5,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| May 16, 2017 Filed May 19, 2017 00:46 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
SaleCommon Stock | 1,450 | $19.55 | $28,347.50 |
DisclosureSEC source: 0001209191-17-033766 · doc4.xml · nonDerivative · entry 1 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,572 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 16, 2017 Filed May 19, 2017 00:45 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
SaleCommon Stock | 1,701 | $19.55 | $33,254.55 |
DisclosureSEC source: 0001209191-17-033764 · doc4.xml · nonDerivative · entry 1 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,803 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.31 to $19.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:02 UTC |
CHESS ROBERTDirector
|
Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-033345 · doc4.xml · derivative · entry 3 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:02 UTC |
CHESS ROBERTDirector
|
SaleCommon Stock | 5,000 | $19.79 | $98,950.00 |
DisclosureSEC source: 0001209191-17-033345 · doc4.xml · nonDerivative · entry 2 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,623 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.60 to $19.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 15, 2017 Filed May 17, 2017 22:02 UTC |
CHESS ROBERTDirector
|
Exercise / conversionCommon Stock | 5,000 | $8.37 | $41,850.00 |
DisclosureSEC source: 0001209191-17-033345 · doc4.xml · nonDerivative · entry 1 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:30 UTC |
CHESS ROBERTDirector
|
Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-027576 · doc4.xml · derivative · entry 3 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:30 UTC |
CHESS ROBERTDirector
|
SaleCommon Stock | 5,000 | $18.72 | $93,600.00 |
DisclosureSEC source: 0001209191-17-027576 · doc4.xml · nonDerivative · entry 2 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,623 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $18.41 to $18.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 17, 2017 Filed Apr 19, 2017 23:30 UTC |
CHESS ROBERTDirector
|
Exercise / conversionCommon Stock | 5,000 | $8.37 | $41,850.00 |
DisclosureSEC source: 0001209191-17-027576 · doc4.xml · nonDerivative · entry 1 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 22:04 UTC |
Lingnau LutzDirector
|
SaleCommon Stock | 7,000 | $20.05 | $140,350.00 |
DisclosureSEC source: 0001209191-17-026605 · doc4.xml · nonDerivative · entry 1 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,450 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $19.68 to $20.89. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:07 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionStock Option · Derivative | 100,000 | $0.00 Strike: $9.53 | $0.00 |
DisclosureSEC source: 0001209191-17-026344 · doc4.xml · derivative · entry 3 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,000 Underlying: Common Stock · 100,000 shares Expires 2018-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:07 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
SaleCommon Stock | 100,000 | $21.70 | $2,170,000.00 |
DisclosureSEC source: 0001209191-17-026344 · doc4.xml · nonDerivative · entry 2 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,504 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.07 to $22.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:07 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
Exercise / conversionCommon Stock | 100,000 | $9.53 | $953,000.00 |
DisclosureSEC source: 0001209191-17-026344 · doc4.xml · nonDerivative · entry 1 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:05 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionStock Option · Derivative | 180,000 | $0.00 Strike: $13.70 | $0.00 |
DisclosureSEC source: 0001209191-17-026343 · doc4.xml · derivative · entry 3 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 180,000 shares Expires 2018-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:05 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 180,000 | $21.70 | $3,906,000.00 |
DisclosureSEC source: 0001209191-17-026343 · doc4.xml · nonDerivative · entry 2 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,648 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $21.07 to $22.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 5,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:05 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
Exercise / conversionCommon Stock | 180,000 | $13.70 | $2,466,000.00 |
DisclosureSEC source: 0001209191-17-026343 · doc4.xml · nonDerivative · entry 1 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,648 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 5,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:01 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionStock Option · Derivative | 15,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-026342 · doc4.xml · derivative · entry 3 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:01 UTC |
KUEBLER CHRISTOPHER ADirector
|
SaleCommon Stock | 15,000 | $21.88 | $328,200.00 |
DisclosureSEC source: 0001209191-17-026342 · doc4.xml · nonDerivative · entry 2 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.58 to $22.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 05, 2017 Filed Apr 7, 2017 22:01 UTC |
KUEBLER CHRISTOPHER ADirector
|
Exercise / conversionCommon Stock | 15,000 | $8.37 | $125,550.00 |
DisclosureSEC source: 0001209191-17-026342 · doc4.xml · nonDerivative · entry 1 KUEBLER CHRISTOPHER A · CIK 0001229877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 22:04 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
Exercise / conversionStock Option · Derivative | 37,500 | $0.00 Strike: $7.21 | $0.00 |
DisclosureSEC source: 0001209191-17-022409 · doc4.xml · derivative · entry 5 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,500 shares Expires 2020-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 22:04 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
Exercise / conversionStock Option · Derivative | 75,000 | $0.00 Strike: $11.34 | $0.00 |
DisclosureSEC source: 0001209191-17-022409 · doc4.xml · derivative · entry 4 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,000 shares Expires 2018-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 22:04 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
SaleCommon Stock | 112,500 | $19.69 | $2,215,125.00 |
DisclosureSEC source: 0001209191-17-022409 · doc4.xml · nonDerivative · entry 3 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,637 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $19.50 to $20.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 22:04 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 37,500 | $7.21 | $270,375.00 |
DisclosureSEC source: 0001209191-17-022409 · doc4.xml · nonDerivative · entry 2 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,137 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 20, 2017 Filed Mar 22, 2017 22:04 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
Exercise / conversionCommon Stock | 75,000 | $11.34 | $850,500.00 |
DisclosureSEC source: 0001209191-17-022409 · doc4.xml · nonDerivative · entry 1 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,637 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:02 UTC |
WHITFIELD ROY ADirector
|
Exercise / conversionStock Option · Derivative | 14,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-021522 · doc4.xml · derivative · entry 3 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 22:02 UTC |
WHITFIELD ROY ADirector
|
Exercise / conversionCommon Stock | 14,000 | $8.37 | $117,180.00 |
DisclosureSEC source: 0001209191-17-021522 · doc4.xml · nonDerivative · entry 1 WHITFIELD ROY A · CIK 0000936728 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 22:02 UTC |
CHESS ROBERTDirector
|
Exercise / conversionStock Option · Derivative | 5,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-17-021166 · doc4.xml · derivative · entry 3 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires 2017-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 22:02 UTC |
CHESS ROBERTDirector
|
SaleCommon Stock | 5,000 | $15.41 | $77,050.00 |
DisclosureSEC source: 0001209191-17-021166 · doc4.xml · nonDerivative · entry 2 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,623 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.18 to $15.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| March 14, 2017 Filed Mar 16, 2017 22:02 UTC |
CHESS ROBERTDirector
|
Exercise / conversionCommon Stock | 5,000 | $8.37 | $41,850.00 |
DisclosureSEC source: 0001209191-17-021166 · doc4.xml · nonDerivative · entry 1 CHESS ROBERT · CIK 0001227886 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,623 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and is related to a stock option that was scheduled to expire on September 14, 2017. Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 25,000 | $0.00 Strike: $9.24 | $0.00 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · derivative · entry 9 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2017-11-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 25,000 stock options scheduled to expire on November 17, 2017. Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 7,494 | $0.00 Strike: $6.34 | $0.00 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · derivative · entry 8 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,494 shares Expires 2017-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017. Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 25,000 | $15.21 | $380,250.00 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · nonDerivative · entry 6 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,270 F5 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 25,000 stock options scheduled to expire on November 17, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 25,000 | $9.24 | $231,000.00 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · nonDerivative · entry 5 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,270 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 25,000 stock options scheduled to expire on November 17, 2017. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 7,494 | $15.21 | $113,983.74 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · nonDerivative · entry 4 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,270 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017. F4 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 03, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 7,494 | $6.34 | $47,511.96 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · nonDerivative · entry 3 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionStock Option · Derivative | 167,506 | $0.00 Strike: $6.34 | $0.00 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · derivative · entry 7 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,494 Underlying: Common Stock · 167,506 shares Expires 2017-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017. Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 167,506 | $15.15 | $2,537,715.90 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · nonDerivative · entry 2 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,270 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017. F3 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| March 02, 2017 Filed Mar 4, 2017 00:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
Exercise / conversionCommon Stock | 167,506 | $6.34 | $1,061,988.04 |
DisclosureSEC source: 0001209191-17-018033 · doc4.xml · nonDerivative · entry 1 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie on March 14, 2016 related to 175,000 stock options scheduled to expire on June 9, 2017. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:32 UTC |
Lingnau LutzDirector
|
Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $5.14 | $0.00 |
DisclosureSEC source: 0001209191-17-014007 · doc4.xml · derivative · entry 3 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2019-09-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:32 UTC |
Lingnau LutzDirector
|
SaleCommon Stock | 30,000 | $13.08 | $392,400.00 |
DisclosureSEC source: 0001209191-17-014007 · doc4.xml · nonDerivative · entry 2 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,450 F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.99 to $13.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 21, 2017 Filed Feb 23, 2017 23:32 UTC |
Lingnau LutzDirector
|
Exercise / conversionCommon Stock | 30,000 | $5.14 | $154,200.00 |
DisclosureSEC source: 0001209191-17-014007 · doc4.xml · nonDerivative · entry 1 Lingnau Lutz · CIK 0001354179 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,450 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: This transaction was made pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:06 UTC |
Thomsen Jillian B.SVP & Chief Accounting Officer
|
SaleCommon Stock | 1,965 | $13.14 | $25,820.10 |
DisclosureSEC source: 0001209191-17-012409 · doc4.xml · nonDerivative · entry 1 Thomsen Jillian B. · CIK 0001433457 · SVP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,637 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 988 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:06 UTC |
ROBIN HOWARD WDirector · President & CEO
|
SaleCommon Stock | 8,636 | $13.14 | $113,477.04 |
DisclosureSEC source: 0001209191-17-012408 · doc4.xml · nonDerivative · entry 1 ROBIN HOWARD W · CIK 0001206869 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,272 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:05 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
SaleCommon Stock | 3,237 | $13.14 | $42,534.18 |
DisclosureSEC source: 0001209191-17-012407 · doc4.xml · nonDerivative · entry 1 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,089 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:04 UTC |
Labrucherie Gil MSVP & Chief Financial Officer
|
SaleCommon Stock | 2,359 | $13.14 | $30,997.26 |
DisclosureSEC source: 0001209191-17-012405 · doc4.xml · nonDerivative · entry 1 Labrucherie Gil M · CIK 0001394875 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,270 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 2,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c). Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:04 UTC |
Hora ManinderSVP Pharma Dev & Mfg Ops
|
SaleCommon Stock | 2,195 | $13.14 | $28,842.30 |
DisclosureSEC source: 0001209191-17-012404 · doc4.xml · nonDerivative · entry 1 Hora Maninder · CIK 0001443159 · SVP Pharma Dev & Mfg Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,648 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: This number includes 5,500 shares held by the reporting person from the Issuer's ESPP plan. The acquisition of these shares under this plan is exempt under Rule 16b-3(c). Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:03 UTC |
Gergel Ivan P.SVP & Chief Medical Officer
|
SaleCommon Stock | 1,457 | $13.14 | $19,144.98 |
DisclosureSEC source: 0001209191-17-012403 · doc4.xml · nonDerivative · entry 1 Gergel Ivan P. · CIK 0001328288 · SVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,022 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 16, 2017 Filed Feb 18, 2017 01:02 UTC |
Doberstein Stephen KSVP & Chief Scientific Officer
|
SaleCommon Stock | 1,261 | $13.14 | $16,569.54 |
DisclosureSEC source: 0001209191-17-012402 · doc4.xml · nonDerivative · entry 1 Doberstein Stephen K · CIK 0001480111 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,504 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.94 to $13.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| February 10, 2017 Filed Feb 11, 2017 01:11 UTC |
Nicholson JohnSVP & Chief Operating Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0000899243-17-003648 · doc4.xml · derivative · entry 2 Nicholson John · CIK 0001420766 · SVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2017-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.